Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.
Publication Type:
Journal ArticleSource:
JAMA, Volume 314, Issue 8, p.811-22 (2015)Keywords:
Adult, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow, Cytarabine, Daunorubicin, Disease-Free Survival, Female, Genome, Human, Humans, Idarubicin, Induction Chemotherapy, Leukemia, Myeloid, Acute, Male, MICRORNAS, Middle Aged, Mutation, Outcome Assessment (Health Care), Polymorphism, Genetic, Prognosis, RECURRENCE, RNA, Messenger, Sequence Analysis, RNAAbstract:
Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML.
Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)